Dow Down 0.08% Nasdaq Down 0.35%

Achillion Pharmaceuticals, Inc. (ACHN)

-NasdaqGS
5.96 Up 0.10(1.71%) Feb 9, 4:00PM EST
Prev Close:5.86
Open:5.75
Bid:4.95 x 400
Ask:11.00 x 300
1y Target Est:10.07
Beta:2.11241
Earnings Date:Mar 3 - Mar 7 (Est.)
Day's Range:5.68 - 6.15
52wk Range:5.67 - 12.94
Volume:1,119,290
Avg Vol (3m):2,053,470
Market Cap:813.81M
P/E (ttm):N/A
EPS (ttm):-0.37
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACHNUp 1.71%813.81M
GSKDown 0.33%95.20B
JNJDown 0.03%282.14B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):23.17
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.12
Quarterly EPS Est (Dec-15) :0.07
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-3.18

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback